Egypt vs Libya: Cause of death, by non-communicable diseases, ages 15-59, female
Egypt
60.0%
in 2021
Libya
60.9%
in 2021
Egypt rank
97th
Libya rank
95th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Egypt
- Libya
How they compare
Libya currently reports 60.9% against 60.0% in Egypt, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Egypt ahead.
Egypt ranks 97th and Libya ranks 95th of 185 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.2% | 68.5% | 14.7% | Egypt |
| 2010s | 88.6% | 68.3% | 20.3% | Egypt |
| 2020s | 65.4% | 62.9% | 2.6% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Egypt or Libya?
- Libya, at 60.9% against 60.0% in Egypt as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Egypt and Libya?
- 0.9%, with Libya ahead.
- How many years of comparable data are there for Egypt and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Egypt and Libya rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Egypt ranks 97th and Libya ranks 95th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.